Kristin Rübsam is a CMC Manager at Adrenomed AG since June 2020. Before that, Kristin worked as a Scientist in Protein Engineering and Assays at Bayer Pharmaceuticals from October 2018 to March 2020. Prior to that, Kristin was a Postdoc at DWI - Leibniz-Institut für Interaktive Materialien from May 2018 to September 2018. Kristin holds a Ph.D. in Biotechnology from RWTH Aachen University, with previous degrees including a Master of Science in Molecular Biotechnology and a Bachelor of Engineering in Biotechnology.
February 1, 2022 - present
June, 2020
Director, Head Of CMC at Insilico Medicine
Vp, Head Of CMC at Oric Pharmaceuticals
Head of CMC, Q3 23 at Molecular Axiom
Head Of CMC Program Development, MSAT And Clinical Supplies at Ichnos Sciences
Head Of CMC Formulation Development And Clinical Supplies at Praxis Medicines
Access the worlds's biggest network of public org charts
Learn more